 |
|
Costs of Illness Due to Bordetella pertussis in Families
Lucia H. Lee, MD;
Michael E. Pichichero, MD
Arch Fam Med. 2000;9:989-996.
Objective To assess costs of pertussis morbidity among families in a community setting.
Design Prospective survey.
Results Sixty-nine families (87 individuals) were studied. Twelve of 14 families with household contacts included an ill adolescent or parent. This individual was the first identified pertussis case within the household in 8 families. A family member required an average of 1.6 visits before (range, 0-7 visits) and after (range, 0-9 visits) pertussis was diagnosed; children younger than 1 year needed 2.5 and 2 visits, respectively. Symptomatic improvement occurred after a mean of 31 days (range, 4-134 days) after pertussis diagnosis and full recovery after a mean of 66 days (range, 5-383 days). Adults experienced the longest recovery time (median, 93 days) compared with other age groups. The average medical costs for an infant, child, adolescent, and adult were $2822, $308, $254, and $181, respectively. Parents lost an average of 6 workdays (range, 1-35 days) to care for an ill child; for these parents, costs associated with work loss averaged $767 per family. An average of 1.7 and 0.7 lost workdays accrued to bring an ill child to a physician's office and the emergency department, respectively. A majority (58%) of parents working while family members were ill with pertussis reported decreased work productivity ranging from 25% to 99%. Work-related costs contributed more than 60% of the overall costs of pertussis.
Conclusions The adverse financial effect of pertussis on 69 families in Monroe County, New York, was $145 903 ($2115 per family) and supports the need for booster immunizations in adolescents and adults.
From the Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Md (Dr Lee); and the Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY (Dr Pichichero).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Administration of Tetanus, Diphtheria, and Acellular Pertussis Vaccine to Parents of High-Risk Infants in the Neonatal Intensive Care Unit
Dylag and Shah
Pediatrics 2008;122:e550-e555.
ABSTRACT
| FULL TEXT
Pertussis Vaccination for Health Care Workers
Sandora et al.
Clin. Microbiol. Rev. 2008;21:426-434.
ABSTRACT
| FULL TEXT
Rationale for Use of Tdap Booster Vaccines for Adolescent Immunization: Overview of Efficacy, Safety, and Clinical Use
Hitchcock
CLIN PEDIATR 2006;45:785-794.
ABSTRACT
Acellular Pertussis Vaccine Booster Combined With Diphtheria and Tetanus Toxoids for Adolescents
Pichichero et al.
Pediatrics 2006;117:1084-1093.
ABSTRACT
| FULL TEXT
|
